Shared decisions for blood thinners in atrial fibrillation
Part of Heart & circulation clinical trials.
This study tests a shared decision-making tool to help Black and White patients with atrial fibrillation choose the right blood thinner to prevent strokes. It aims to make sure everyone gets equal care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are Black or White.
- You have been diagnosed with atrial fibrillation (A-fib) that is not caused by a heart valve problem.
- Your stroke risk score is 2 or higher.
- You are starting a blood thinner for the first time at a primary care or heart clinic.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a web-based decision aid that helps people with atrial fibrillation (AF) decide about stroke-prevention treatment, such as blood thinners. It may help you feel more confident and make safer choices by showing options at the right time after diagnosis.
This study tests a computer tool that helps doctors decide if you need a blood thinner to lower your stroke risk. If you have atrial fibrillation (irregular heartbeat) and haven't been prescribed a blood thinner yet, this might help protect you.
This study tests an electronic decision-support tool used in the emergency department (ED) to help clinicians choose the safest way to prevent stroke when atrial fibrillation is newly found. It may help by improving how quickly and consistently stroke-prevention treatment is considered.
This study tests whether using a smartwatch to monitor your heartbeat can safely guide when to take blood thinners. If you have intermittent atrial fibrillation, you may be able to avoid taking blood thinners when your heart rhythm is normal.
This study compares two blood-thinning medicines to see which works better for people who have both atrial fibrillation (irregular heartbeat) and heart disease. It aims to reduce the risk of heart attack or stroke while avoiding bleeding problems.
This trial follows people with atrial fibrillation to see how long-term blood-thinning treatment affects outcomes over time. It may help determine which long-term approach best lowers stroke and clot risks for patients like you.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.